• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

秋水仙碱对家族性地中海热中炎性细胞因子和选择素的影响。

Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean fever.

作者信息

Kiraz S, Ertenli I, Arici M, Calgüneri M, Haznedaroglu I, Celik I, Pay S, Kirazli S

机构信息

Hacettepe University, School of Medicine, Department of Internal Medicine, Ankara, Turkey.

出版信息

Clin Exp Rheumatol. 1998 Nov-Dec;16(6):721-4.

PMID:9844766
Abstract

OBJECTIVE

To evaluate whether basal levels of circulating cytokines and selectins exhibit a distinct profile in attack-free, non-colchicine taking familial Mediterranean fever (FMF) patients compared to normal healthy controls, and to determine the effect of colchicine treatment on these parameters.

METHODS

Serum levels of interleukin (IL)-6, IL-8, tumor necrosis factor (TNF)-alpha, and soluble P-, E-, and L-selectin in attack-free, asymptomatic, non-colchicine using FMF patients (n = 11) and in normal controls (n = 10) were studied. Following 2 months of colchicine treatment the same parameters were evaluated again in the FMF patients.

RESULTS

Before colchicine treatment the serum levels of all parameters except soluble P-selectin were significantly higher in FMF patients than in controls. After two months of treatment statistically significant decreases were observed in these parameters (p < 0.05).

CONCLUSION

A distinct profile of IL-6, IL-8, TNF-alpha, and soluble E- and L-selectin levels was observed in FMF patients, which could reflect the presence of sustained inflammation in attack-free FMF patients. The effect of colchicine on these parameters suggests its therapeutic potential.

摘要

目的

评估无发作、未服用秋水仙碱的家族性地中海热(FMF)患者与正常健康对照相比,循环细胞因子和选择素的基础水平是否呈现不同特征,并确定秋水仙碱治疗对这些参数的影响。

方法

研究了无发作、无症状、未使用秋水仙碱的FMF患者(n = 11)和正常对照(n = 10)血清中白细胞介素(IL)-6、IL-8、肿瘤坏死因子(TNF)-α以及可溶性P-、E-和L-选择素的水平。在FMF患者接受2个月秋水仙碱治疗后,再次评估相同参数。

结果

在秋水仙碱治疗前,除可溶性P-选择素外,FMF患者所有参数的血清水平均显著高于对照组。治疗2个月后,这些参数出现统计学上的显著下降(p < 0.05)。

结论

在FMF患者中观察到IL-6、IL-8、TNF-α以及可溶性E-和L-选择素水平的独特特征,这可能反映了无发作的FMF患者存在持续性炎症。秋水仙碱对这些参数的影响表明了其治疗潜力。

相似文献

1
Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean fever.秋水仙碱对家族性地中海热中炎性细胞因子和选择素的影响。
Clin Exp Rheumatol. 1998 Nov-Dec;16(6):721-4.
2
Increased asymmetric dimethylarginine levels in young men with familial Mediterranean fever (FMF): is it early evidence of interaction between inflammation and endothelial dysfunction in FMF?家族性地中海热(FMF)青年男性中不对称二甲基精氨酸水平升高:这是FMF中炎症与内皮功能障碍相互作用的早期证据吗?
J Rheumatol. 2008 Oct;35(10):2024-9. Epub 2008 Sep 1.
3
Can the Thiol/Disulfide Imbalance Be a Predictor of Colchicine Resistance in Familial Mediterranean Fever?硫醇/二硫键失衡可否预测家族性地中海热患者对秋水仙碱的耐药性?
J Korean Med Sci. 2017 Oct;32(10):1588-1594. doi: 10.3346/jkms.2017.32.10.1588.
4
Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients.家族性地中海热患者血清可溶性白细胞介素-2受体、白细胞介素-6、白细胞介素-10和肿瘤坏死因子-α水平
Clin Rheumatol. 2003 May;22(2):99-101. doi: 10.1007/s10067-002-0682-1.
5
The Value of Serum Amyloid A Levels in Familial Mediterranean Fever to Identify Occult Inflammation During Asymptomatic Periods.血清淀粉样蛋白 A 水平在家族性地中海热无症状期识别隐匿性炎症中的价值。
J Clin Rheumatol. 2021 Jan 1;27(1):1-4. doi: 10.1097/RHU.0000000000001134.
6
Update on the management of colchicine resistant Familial Mediterranean Fever (FMF).关于难治性家族性地中海热(FMF)的管理进展。
Orphanet J Rare Dis. 2019 Oct 15;14(1):224. doi: 10.1186/s13023-019-1201-7.
7
Neutrophil-lymphocyte ratio in patients with familial Mediterranean fever.家族性地中海热患者的中性粒细胞与淋巴细胞比值
J Clin Lab Anal. 2015 Jan;29(1):80-3. doi: 10.1002/jcla.21732. Epub 2014 Mar 28.
8
Effects of anti-tumor necrosis factor agents for familial mediterranean fever patients with chronic arthritis and/or sacroiliitis who were resistant to colchicine treatment.肿瘤坏死因子拮抗剂治疗对秋水仙碱治疗抵抗的伴有慢性关节炎和/或骶髂关节炎的家族性地中海热患者的疗效。
J Clin Rheumatol. 2011 Oct;17(7):358-62. doi: 10.1097/RHU.0b013e31823682f5.
9
Evaluation of hearing in pediatric familial Mediterranean fever patients during attack period and attack-free period.小儿家族性地中海热患者发作期和发作间期听力评估
Int J Pediatr Otorhinolaryngol. 2019 Apr;119:185-192. doi: 10.1016/j.ijporl.2019.01.042. Epub 2019 Feb 1.
10
Is there a relationship between serum omentin level and acute phase response in patients with familial Mediterranean fever?家族性地中海热患者血清网膜素水平与急性期反应之间存在关联吗?
Clin Rheumatol. 2021 Feb;40(2):669-674. doi: 10.1007/s10067-020-05249-3. Epub 2020 Jul 4.

引用本文的文献

1
Colchicine for the primary prevention of cardiovascular events.秋水仙碱用于心血管事件的一级预防。
Cochrane Database Syst Rev. 2025 Feb 10;2(2):CD015003. doi: 10.1002/14651858.CD015003.pub2.
2
Update on the Role of Colchicine in Cardiovascular Disease.秋水仙碱在心血管疾病中作用的最新进展
Curr Cardiol Rep. 2024 Apr;26(4):191-198. doi: 10.1007/s11886-024-02026-5. Epub 2024 Feb 10.
3
Interventions for reducing inflammation in familial Mediterranean fever.家族性地中海热的抗炎干预措施。
Cochrane Database Syst Rev. 2022 Mar 29;3(3):CD010893. doi: 10.1002/14651858.CD010893.pub4.
4
Purinergic receptor ligands: the cytokine storm attenuators, potential therapeutic agents for the treatment of COVID-19.嘌呤能受体配体:细胞因子风暴的抑制剂,治疗 COVID-19 的潜在治疗药物。
Immunopharmacol Immunotoxicol. 2021 Dec;43(6):633-643. doi: 10.1080/08923973.2021.1988102. Epub 2021 Oct 14.
5
Tofacitinib for the treatment for colchicine-resistant familial Mediterranean fever: case-based review.托法替布治疗秋水仙碱抵抗的家族性地中海热:基于病例的综述。
Rheumatol Int. 2020 Jan;40(1):169-173. doi: 10.1007/s00296-019-04490-7. Epub 2019 Dec 7.
6
Update on the management of colchicine resistant Familial Mediterranean Fever (FMF).关于难治性家族性地中海热(FMF)的管理进展。
Orphanet J Rare Dis. 2019 Oct 15;14(1):224. doi: 10.1186/s13023-019-1201-7.
7
Evodiamine Augments NLRP3 Inflammasome Activation and Anti-bacterial Responses Through Inducing α-Tubulin Acetylation.吴茱萸碱通过诱导α-微管蛋白乙酰化增强NLRP3炎性小体激活和抗菌反应。
Front Pharmacol. 2019 Mar 26;10:290. doi: 10.3389/fphar.2019.00290. eCollection 2019.
8
Interventions for reducing inflammation in familial Mediterranean fever.降低家族性地中海热炎症的干预措施。
Cochrane Database Syst Rev. 2018 Oct 19;10(10):CD010893. doi: 10.1002/14651858.CD010893.pub3.
9
Cardiac disease in familial Mediterranean fever.家族性地中海热相关的心脏疾病。
Rheumatol Int. 2018 Jan;38(1):51-58. doi: 10.1007/s00296-017-3853-8. Epub 2017 Oct 20.
10
Evaluation of endothelial dysfunction in patients with familial Mediterranean fever: the relationship between the levels of asymmetric dimethylarginine and endocan with carotid intima-media thickness and endothelium-dependent vasodilation.家族性地中海热患者内皮功能障碍的评估:不对称二甲基精氨酸和内脂素水平与颈动脉内膜中层厚度和内皮依赖性血管舒张的关系。
Clin Rheumatol. 2017 Sep;36(9):2071-2077. doi: 10.1007/s10067-016-3532-2. Epub 2017 Jan 10.